In the last 6 years, only 1.67 % trading sessions saw intraday declines higher than 5 % .
Aster DM Healthcare Share Price
Aster DM Healthcare Sha...
Aster DM Health share price insights
Sales de-grew by 69.0%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
5 day moving crossover appeared yesterday. Average price decline of -2.38% within 7 days of this signal in last 5 years.
Stock gave a 3 year return of 105.97% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)
Aster DM Healthcare Ltd. share price moved up by 1.14% from its previous close of Rs 402.15. Aster DM Healthcare Ltd. stock last traded price is 406.70
Share Price Value Today/Current/Last 406.70 Previous Day 402.15
Key Metrics
PE Ratio (x) | 3.86 | ||||||||||
EPS - TTM (₹) | 105.49 | ||||||||||
MCap (₹ Cr.) | 20,315.20 | ||||||||||
Sectoral MCap Rank | 8 | ||||||||||
PB Ratio (x) | 3.99 | ||||||||||
Div Yield (%) | 0.00 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 1.70 | ||||||||||
VWAP (₹) | 406.36 | ||||||||||
52W H/L (₹) |
Aster DM Health Share Price Returns
1 Day | 1.14% |
1 Week | 1.59% |
1 Month | 16.85% |
3 Months | 14.1% |
1 Year | 22.8% |
3 Years | 89.12% |
5 Years | 244.22% |
Aster DM Health News & Analysis
NewsOlympus Capital Asia divests 9% stake in Aster DM Healthcare for Rs 1,530 crore
NewsStocks in news: YES Bank, Aster DM Healthcare, ONGC, IndiGo, Bank of Baroda
NewsPrivate equity firm Olympus to sell upto 10% stake in Aster DM Healthcare on Friday
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcements
Aster DM Health Share Recommendations
Recent Recos
Current
Mean Recos by 6 Analysts
SellSellHoldBuyStrong
Buy
That's all for Aster DM Health recommendations. Check out other stock recos.
Analyst Trends
Ratings | Current | 1 Week Ago | 1 Month Ago | 3 Months Ago |
---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 3 |
Buy | 3 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | - |
Sell | - | - | - | - |
Strong Sell | - | - | - | - |
# Analysts | 6 | 6 | 6 | 6 |
Aster DM Health Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Topline Contraction
Sales de-grew by 69.0%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent 2.98% of its operating revenues towards interest expenses and 18.27% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 1,050.59 977.67 3,718.56 3,325.22 3,224.57 Total Income Growth (%) 7.46 -73.71 11.83 3.12 -1.58 Total Expenses 898.74 872.61 3,378.01 3,221.14 3,045.12 Total Expenses Growth (%) 2.99 -74.17 4.87 5.78 2.35 EBIT 151.85 105.06 340.55 104.08 179.45 EBIT Growth (%) 44.54 -69.15 227.20 -42.00 -40.39 Profit after Tax (PAT) 5,145.18 -24.03 179.21 -30.79 4.90 PAT Growth (%) - -113.41 - -728.37 -97.13 EBIT Margin (%) 14.45 10.75 9.16 3.13 5.57 Net Profit Margin (%) 489.74 -2.46 4.82 -0.93 0.15 Basic EPS (₹) 103.34 -0.48 3.60 -0.62 0.10 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 17,991.31 14,881.20 12,546.24 11,643.46 12,437.84 Total Assets Growth (%) 20.90 18.61 7.75 -6.39 39.18 Total Liabilities 12,961.20 10,020.74 8,063.62 7,809.34 8,719.33 Total Liabilities Growth (%) 29.34 24.27 3.26 -10.44 65.87 Total Equity 5,030.11 4,486.08 4,482.62 3,834.12 3,344.13 Total Equity Growth (%) 12.13 0.08 16.91 14.65 1.17 Current Ratio (x) 1.25 1.06 1.15 1.14 1.10 Total Debt to Equity (x) 0.15 0.56 0.55 0.57 0.86 Contingent Liabilities 480.16 365.46 381.30 299.39 287.00 All figures in Rs Cr, unless mentioned otherwise
Insights
Decrease in Cash from Investing
Company has used Rs 884.65 cr for investing activities which is an YoY decrease of 8.98%. (Source: Consolidated Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 157.81 1,833.98 1,313.46 1,569.12 1,223.25 Net Cash used in Investing Activities -884.65 -971.88 -570.48 -330.30 -667.28 Net Cash flow from Financing Activities 1,052.83 -817.39 -685.42 -1,116.13 -674.80 Net Cash Flow 332.39 65.74 64.78 119.90 -109.92 Closing Cash & Cash Equivalent 697.46 365.07 299.33 234.55 114.65 Closing Cash & Cash Equivalent Growth (%) 91.05 21.96 27.62 104.58 -48.95 Total Debt/ CFO (x) 4.24 1.25 1.67 1.22 2.03 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 2.83 10.43 13.30 4.38 9.54 Return on Capital Employed (%) 5.71 8.44 9.93 5.86 8.14 Return on Assets (%) 0.71 2.85 4.19 1.26 2.22 Interest Coverage Ratio (x) 5.47 4.99 5.97 1.69 1.97 Asset Turnover Ratio (x) 0.23 0.18 0.14 73.93 70.25 Price to Earnings (x) 158.73 28.41 18.62 46.30 17.24 Price to Book (x) 4.48 2.96 2.48 2.02 1.65 EV/EBITDA (x) 35.61 8.72 7.91 8.02 5.80 EBITDA Margin (%) 16.29 13.77 14.96 12.92 14.82
Aster DM Health Peer Comparison
Aster DM Health Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of 105.97% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated 105.97% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of 105.97% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)Stock Returns vs BSE Healthcare
Stock generated 105.97% return as compared to BSE Healthcare which gave investors 64.6% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
MF Ownership details are not available.
Corporate Actions
Aster DM Health Board Meeting/AGM
Aster DM Health Dividends
- Others
Meeting Date Announced on Purpose Details Jul 31, 2024 Jul 25, 2024 Board Meeting Quarterly Results May 28, 2024 May 23, 2024 Board Meeting Audited Results & Final Dividend Apr 12, 2024 Apr 05, 2024 Board Meeting Interim Dividend & Special Dividend Feb 08, 2024 Feb 02, 2024 Board Meeting Quarterly Results Jan 24, 2024 Dec 26, 2023 POM - Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 20% 2.0 Aug 22, 2024 May 28, 2024 Interim 0% 0.0 Apr 23, 2024 Apr 05, 2024 Special 1180% 118.0 Apr 23, 2024 Apr 05, 2024 No other corporate actions details are available.
About Aster DM Health
Aster DM Healthcare Ltd., incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 20,087.92 Crore) operating in Hospitals & Allied Services sector. Aster DM Healthcare Ltd. key Products/Revenue Segments include Hospital Services, Pharmaceuticals, Other Operating Revenue, Other Services and Consultancy Income for the year ending 31-Mar-2024. Show More
Executives
Auditors
- AM
Azad Moopen
Founder Chairman & Mng. DirectorAMAlisha Moopen
Deputy Managing DirectorNSNitish Shetty
Chief Executive OfficerDRDaniel Robert Mintz
Non Executive DirectorShow More - Deloitte Haskins & Sells
Industry
Key Indices Listed on
Nifty 500, BSE 500, BSE 250 SmallCap Index, + 10 more
Address
Awfis, 2nd Floor, Renaissance Centra,27 & 27/1, Mission Road,Sampangi Rama Nagar,Bengaluru, Kerala - 560027
More Details
Trending in Markets
Aster DM Health Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.